#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital hypotransferrinaemia Netherton's syndrome Retinopathy of prematurity Intracranial germ cell tumour Neuroendocrine carcinoma Cutaneous T-cell lymphoma stage I Cluster headache Transient ischaemic attack Glomerulonephritis membranoproliferative Colitis ulcerative Anti-myelin-associated glycoprotein antibodies positive Primitive neuroectodermal tumour White matter lesion Osteochondrodysplasia Castleman's disease More trials…

    Learn about Rare Diseases

    Osteosarcoma – Diagnostics Hereditary angioedema with C1 esterase inhibitor deficiency Basal cell naevus syndrome – Treatment Thrombotic thrombocytopenic purpura – Life with Disease Waldenstrom’s macroglobulinaemia recurrent Synovial sarcoma metastatic – Treatment Glycogen storage disease type V Epidermolysis bullosa – Trials in Disease IgA nephropathy – Trials in Disease Indolent systemic mastocytosis – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    SUMATRIPTAN Specific Nucleic Acid Sna-Xfsc Pyridoxine Hydrochloride Mosaic Hbcoreag Cetrorelix Db-1303 Nemvaleukin Alfa IG-TREGS BENZYDAMINE HYDROCHLORIDE Sirexatamab Niraparib Tosilate Monohydrate Sodium Sulfate Anhydrous Valganciclovir Hydrochloride Regn5668 Belumosudil Mesilate Histidine Platelet Concentrate Guanfacine Glucose Monohydrate Ph. Eur. Mrna-3210 More therapies…

    Learn about Your Condition

    Retinitis pigmentosa Pulmonary resection Cervix carcinoma stage II Thrombocytopenia Neurodegenerative disorder Post-acute COVID-19 syndrome Behavioural addiction Anaemia of chronic disease Ocular melanoma Bladder cancer recurrent Cholestatic pruritus Decreased appetite Palmoplantar pustulosis Postpartum haemorrhage Rectal adenocarcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Cholangiocarcinoma

  • Study of Gemcitabine and Oxaliplatin Infusion for Patients with Non-Metastatic Unresectable Intra-Hepatic Cholangiocarcinoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cholangiocarcinoma
    Investigated Drugs:
    • Gemcitabine Hydrochloride
    • Oxaliplatin
    France

  • Study on Pre-Surgery Treatment for Locally Advanced Cholangiocarcinoma Using Durvalumab, Tremelimumab, Cisplatin, and Gemcitabine

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cholangiocarcinoma
    Investigated Drugs:
    • Tremelimumab
    • Cisplatin
    • Durvalumab
    Italy

  • Study on Preventing Liver Recurrence in Patients with Intrahepatic Cholangiocarcinoma Using Floxuridine via Hepatic Arterial Infusion Pump

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cholangiocarcinoma
    The Netherlands

  • Study on the Effectiveness of Yttrium-90 Microspheres and Capecitabine for Patients with Operable Intrahepatic Cholangiocarcinoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cholangiocarcinoma
    Investigated Drugs:
    • Capecitabine
    France

  • Title: Evaluation of Gallium-68 FAPI-46 PET Imaging for Better Detection and Monitoring of Pancreatic Cancer and Bile Duct Cancer

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    • Cholangiocarcinoma
    Investigated Drugs:
    • Gallium (68Ga) Chloride
    The Netherlands

  • Study of Chemotherapy with or without FUDR/Dexamethasone for Patients with Inoperable Liver Bile Duct Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Cholangiocarcinoma
    Investigated Drugs:
    • Floxuridine
    The Netherlands
Previous Page
1 2 3 4 … 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!